In conclusion the results of this study indicate the impact of the estradiol and several SERM and SERD compounds, in particular RU39,411 and RU58,668, on nucleocytoplasmic shuttling and protein turnover of estrogen receptor alpha (ERα) in human breast cancer cell lines. This evidence concerns the gene ERAL1 and breast carcinoma.